{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:57:21Z","timestamp":1792000641986,"version":"4.4.0"},"reference-count":32,"publisher":"American Veterinary Medical Association (AVMA)","license":[{"start":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T00:00:00Z","timestamp":1791936000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["javma"],"published-print":{"date-parts":[[2026,10,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To determine the prevalence of the 2-bp deletion genetic variant (\n                      <jats:italic>ABCB1<\/jats:italic>\n                      c.1930_1931delTC) in the feline multidrug resistance\n                      <jats:italic>ABCB1<\/jats:italic>\n                      (previously\n                      <jats:italic>MDR1<\/jats:italic>\n                      ) gene, which has been associated with sensitivity to P-glycoprotein (P-gp) substrate drugs in cats with homozygous mutations, utilizing a large population screen of genomic DNA samples from purebred and mixed-breed domestic cats in the US.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional epidemiological study utilized conveniently available, unbiased, residual whole blood samples that were obtained from 12,000 US domestic cats and submitted to Idexx Laboratories between March and October 2025. Variant detection was performed with a validated dual-probe real-time PCR assay to detect 3 potential genotypes: wild type, homozygous mutant for variant allele, or heterozygous.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A majority of the cats tested were wild type (&gt; 98%), while 1.5% (181 cats) had the heterozygous genotype. Only 0.025% (3 cats) were homozygous for the\n                      <jats:italic>ABCB1<\/jats:italic>\n                      c.1930_1931delTC variant. The variant allele frequency was 0.8%.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      This survey of domestic pet cats in the US demonstrated that the prevalence of the homozygous\n                      <jats:italic>ABCB1<\/jats:italic>\n                      c.1930_1931delTC variant is rare.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Relevance<\/jats:title>\n                    <jats:p>\n                      The low prevalence of homozygous mutations in cats in this large-scale survey provides veterinarians confidence in prescribing products that are P-gp substrates, such as cyclosporine, loperamide, emodepside, and macrocyclic lactones (ivermectin, eprinomectin, selamectin, milbemycin oxime, and moxidectin). If concerns arise for individual cats, veterinarians can consider\n                      <jats:italic>ABCB1<\/jats:italic>\n                      genotyping prior to administering P-gp substrates. While these results provide information on the prevalence of\n                      <jats:italic>ABCB1<\/jats:italic>\n                      c.1930_1931delTC, future research on other known polymorphisms will help us fully understand\n                      <jats:italic>ABCB1<\/jats:italic>\n                      \/\n                      <jats:italic>MDR1<\/jats:italic>\n                      mutations in cats.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.2460\/javma.26.06.0483","type":"journal-article","created":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:36:17Z","timestamp":1791999377000},"page":"1-9","source":"Crossref","is-referenced-by-count":0,"title":["The prevalence of MDR1\/ABCB1 c.1930_1931delTC variant is rare in US domestic cats"],"prefix":"10.2460","author":[{"given":"Aashish","family":"Joshi","sequence":"first","affiliation":[{"name":"Boehringer Ingelheim Animal Health, Duluth, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Becky","family":"Fankhauser","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Animal Health, Athens, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Hansen","sequence":"additional","affiliation":[{"name":"Idexx BioAnalytics, Columbia, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S.","family":"Livingston","sequence":"additional","affiliation":[{"name":"Idexx BioAnalytics, Columbia, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Young","sequence":"additional","affiliation":[{"name":"Boehringer Ingelheim Vetmedica GmbH, Ingelheim am Rhein, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3077-0201","authenticated-orcid":true,"given":"Jeba R. J.","family":"Jesudoss Chelladurai","sequence":"additional","affiliation":[{"name":"College of Veterinary Medicine, Auburn University, Auburn, AL"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1272","reference":[{"issue":"7","key":"ref1","series-title":"Curr Med Chem","first-page":"1251","article-title":"Role of ABC transporters in veterinary medicine: pharmaco-toxicological implications","volume":"26","author":"Virkel G","year":"2019","unstructured":"Virkel G, Ballent M, Lanusse C, Lifschitz A. Role of ABC transporters in veterinary medicine: pharmaco-toxicological implications. Curr Med Chem. 2019;26(7):1251-1269. doi:10.2174\/0929867325666180201094730"},{"issue":"1","key":"ref2","series-title":"Biochim Biophys Acta","first-page":"152","article-title":"A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants","volume":"455","author":"Juliano RL","year":"1976","unstructured":"Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta. 1976;455(1):152-162. doi:10.1016\/0005-2736(76)90160-7"},{"issue":"4750","key":"ref3","series-title":"Science","first-page":"643","article-title":"Human multidrug-resistant cell lines: increased MDR1 expression can precede gene amplification","volume":"232","author":"Shen DW","year":"1986","unstructured":"Shen DW, Fojo A, Chin JE,  Human multidrug-resistant cell lines: increased MDR1 expression can precede gene amplification. Science. 1986;232(4750):643-645. doi:10.1126\/science.3457471"},{"issue":"4","key":"ref4","series-title":"Cell","first-page":"491","article-title":"Disruption of the mouse MDR1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs","volume":"77","author":"Schinkel AH","year":"1994","unstructured":"Schinkel AH, Smit JJ, van Tellingen O,  Disruption of the mouse MDR1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs. Cell. 1994;77(4):491-502. doi:10.1016\/0092-8674(94)90212-7"},{"issue":"8","key":"ref5","series-title":"Pharmacogenetics","first-page":"727","article-title":"Ivermectin sensitivity in Collies is associated with a deletion mutation of the MDR1 gene","volume":"11","author":"Mealey KL","year":"2001","unstructured":"Mealey KL, Bentjen SA, Gay JM, Cantor GH. Ivermectin sensitivity in Collies is associated with a deletion mutation of the MDR1 gene. Pharmacogenetics. 2001;11(8):727-733. doi:10.1097\/00008571-200111000-00012"},{"issue":"6","key":"ref6","series-title":"Curr Pharm Biotechnol","first-page":"969","article-title":"Treatment of MDR1 mutant dogs with macrocyclic lactones","volume":"13","author":"Geyer J","year":"2012","unstructured":"Geyer J, Janko C. Treatment of MDR1 mutant dogs with macrocyclic lactones. Curr Pharm Biotechnol. 2012;13(6):969-986. doi:10.2174\/138920112800399301"},{"issue":"1","key":"ref7","series-title":"J Vet Pharmacol Ther","first-page":"1","article-title":"Canine and feline P-glycoprotein deficiency: what we know and where we need to go","volume":"46","author":"Mealey KL","year":"2023","unstructured":"Mealey KL, Owens JG, Freeman E. Canine and feline P-glycoprotein deficiency: what we know and where we need to go. J Vet Pharmacol Ther. 2023;46(1):1-16. doi:10.1111\/jvp.13102"},{"issue":"6","key":"ref8","series-title":"Anat Histol Embryol","first-page":"455","article-title":"Tissue distribution of p-glycoprotein in cats","volume":"38","author":"Van Der Heyden S","year":"2009","unstructured":"Van Der Heyden S, Chiers K, Ducatelle R. Tissue distribution of p-glycoprotein in cats. Anat Histol Embryol. 2009;38(6):455-460. doi:10.1111\/j.1439-0264.2009.00972.x"},{"key":"ref9","series-title":"Front Vet Sci","first-page":"808392","article-title":"Detection of the ABCB11930_1931del TC mutation in two suspected ivermectin-sensitive cats and their relatives by a novel TaqMan allelic discrimination assay","volume":"8","author":"N\u00fcrnberger D","year":"2022","unstructured":"N\u00fcrnberger D, Wagner L, M\u00fcller SF,  Detection of the ABCB11930_1931del TC mutation in two suspected ivermectin-sensitive cats and their relatives by a novel TaqMan allelic discrimination assay. Front Vet Sci. 2022;8:808392. doi:10.3389\/fvets.2021.808392"},{"issue":"5","key":"ref10","series-title":"J Vet Pharmacol Ther","first-page":"429","article-title":"Identification of a nonsense mutation in feline ABCB1","volume":"38","author":"Mealey KL","year":"2015","unstructured":"Mealey KL, Burke NS. Identification of a nonsense mutation in feline ABCB1. J Vet Pharmacol Ther. 2015;38(5):429-433. doi:10.1111\/jvp.12212"},{"issue":"3","key":"ref11","series-title":"J Vet Pharmacol Ther","first-page":"226","article-title":"Application of eprinomectin-containing parasiticides at label doses causes neurological toxicosis in cats homozygous for ABCB11930_1931del TC","volume":"47","author":"Mealey KL","year":"2024","unstructured":"Mealey KL, Burke NS, Villarino NF, Court MH, Heusser JP. Application of eprinomectin-containing parasiticides at label doses causes neurological toxicosis in cats homozygous for ABCB11930_1931del TC. J Vet Pharmacol Ther. 2024;47(3):226-230. doi:10.1111\/jvp.13431"},{"issue":"11","key":"ref12","series-title":"J Am Vet Med Assoc","first-page":"1414","article-title":"Avermectin-induced neurotoxicity and mortality reported more commonly in cats homozygous for ABCB11930_1931del TC after application of eprinomectin- versus selamectin-containing products","volume":"263","author":"Mealey KL","year":"2025","unstructured":"Mealey KL, Burke NS, Huesser J, Court MH, Cline N, Villarino NF. Avermectin-induced neurotoxicity and mortality reported more commonly in cats homozygous for ABCB11930_1931del TC after application of eprinomectin- versus selamectin-containing products. J Am Vet Med Assoc. 2025;263(11):1414-1419. doi:10.2460\/javma.25.05.0304"},{"issue":"3","key":"ref13","series-title":"J Vet Pharmacol Ther","first-page":"237","article-title":"Functional characterization of the cat and dog wild-type and mutant MDR1 carrier proteins and frequency of the MDR1 gene mutation in 800 cats from Germany","volume":"49","author":"Siegl L","year":"2026","unstructured":"Siegl L, Beth\u00e4user M, N\u00fcrnberger D,  Functional characterization of the cat and dog wild-type and mutant MDR1 carrier proteins and frequency of the MDR1 gene mutation in 800 cats from Germany. J Vet Pharmacol Ther. 2026;49(3):237-256. doi:10.1111\/jvp.70041"},{"issue":"1","key":"ref14","series-title":"J Am Vet Med Assoc","first-page":"72","article-title":"Role of an ABCB11930_1931del TC gene mutation in a temporal cluster of macrocyclic lactone-induced neurologic toxicosis in cats associated with products labeled for companion animal use","volume":"259","author":"Mealey KL","year":"2021","unstructured":"Mealey KL, Burke NS, Connors RL. Role of an ABCB11930_1931del TC gene mutation in a temporal cluster of macrocyclic lactone-induced neurologic toxicosis in cats associated with products labeled for companion animal use. J Am Vet Med Assoc. 2021;259(1):72-76. doi:10.2460\/javma.259.1.72"},{"issue":"6","key":"ref15","series-title":"PLoS Genet","first-page":"e1009804","article-title":"Genetic epidemiology of blood type, disease and trait variants, and genome-wide genetic diversity in over 11,000 domestic cats","volume":"18","author":"Anderson H","year":"2022","unstructured":"Anderson H, Davison S, Lytle KM,  Genetic epidemiology of blood type, disease and trait variants, and genome-wide genetic diversity in over 11,000 domestic cats. PLoS Genet. 2022;18(6):e1009804. doi:10.1371\/journal.pgen.1009804"},{"key":"ref16","series-title":"Softw Impacts","first-page":"100099","article-title":"zipcodeR: advancing the analysis of spatial data at the zip code level in R","volume":"9","author":"Rozzi GC","year":"2021","unstructured":"Rozzi GC. zipcodeR: advancing the analysis of spatial data at the zip code level in R. Softw Impacts. 2021;9:100099. doi:10.1016\/j.simpa.2021.100099"},{"key":"ref17","series-title":"Spatial Data Science: With Applications in R","author":"Pebesma E","year":"2023","unstructured":"Pebesma E, Bivand R. Spatial Data Science: With Applications in R. Chapman and Hall\/CRC; 2023. doi:10.1201\/9780429459016"},{"key":"ref18","series-title":"tigris: Load Census TIGER\/Line Shapefiles","author":"Walker K","year":"2025","unstructured":"Walker K. tigris: Load Census TIGER\/Line Shapefiles. Version 2.2.1.9000. R Project for Statistical Computing; 2025."},{"issue":"2","key":"ref19","series-title":"Wiley Interdiscip Rev Comput Stat","first-page":"180","article-title":"ggplot2","volume":"3","author":"Wickham H","year":"2011","unstructured":"Wickham H. ggplot2. Wiley Interdiscip Rev Comput Stat. 2011;3(2):180-185. doi:10.1002\/wics.147"},{"key":"ref20","series-title":"T P patchwork: The Composer of Plots","year":"2025","unstructured":"T P patchwork: The Composer of Plots. Version 1.3.2.9000. R Project for Statistical Computing; 2025."},{"key":"ref21","series-title":"An R Companion to Applied Regression","author":"Fox J","year":"2018","unstructured":"Fox J, Weisberg S. An R Companion to Applied Regression. Sage Publications; 2018."},{"issue":"109","key":"ref22","series-title":"J Open Source Softw","first-page":"7969","article-title":"modelbased: an R package to make the most out of your statistical models through marginal means, marginal effects, and model predictions","volume":"10","author":"Makowski D","year":"2025","unstructured":"Makowski D, Ben-Shachar MS, Wiernik BM, Patil I, Th\u00e9riault R, L\u00fcdecke D. modelbased: an R package to make the most out of your statistical models through marginal means, marginal effects, and model predictions. J Open Source Softw. 2025;10(109):7969. doi:10.21105\/joss.07969"},{"key":"ref23","series-title":"R News","first-page":"40","article-title":"meta: an R package for meta-analysis","volume":"7","author":"Schwarzer G","year":"2007","unstructured":"Schwarzer G. meta: an R package for meta-analysis. R News. 2007;7:40-45."},{"issue":"3","key":"ref24","series-title":"Control Clin Trials","first-page":"177","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian R","year":"1986","unstructured":"DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188. doi:10.1016\/0197-2456(86)90046-2"},{"issue":"1","key":"ref25","series-title":"Genome Med","first-page":"16","article-title":"Rare variant association studies: considerations, challenges and opportunities","volume":"7","author":"Auer PL","year":"2015","unstructured":"Auer PL, Lettre G. Rare variant association studies: considerations, challenges and opportunities. Genome Med. 2015;7(1):16. doi:10.1186\/s13073-015-0138-2"},{"issue":"3","key":"ref26","series-title":"Clin Pharmacol Ther","first-page":"563","article-title":"An evidence-based framework for evaluating pharmacogenomics knowledge for personalized medicine","volume":"110","author":"Whirl-Carrillo M","year":"2021","unstructured":"Whirl-Carrillo M, Huddart R, Gong L,  An evidence-based framework for evaluating pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther. 2021;110(3):563-572. doi:10.1002\/cpt.2350"},{"issue":"1","key":"ref27","series-title":"Nat Commun","first-page":"4674","article-title":"Cohort-wide deep whole genome sequencing and the allelic architecture of complex traits","volume":"9","author":"Gilly A","year":"2018","unstructured":"Gilly A, Suveges D, Kuchenbaecker K,  Cohort-wide deep whole genome sequencing and the allelic architecture of complex traits. Nat Commun. 2018;9(1):4674. doi:10.1038\/s41467-018-07070-8. Published correction appears in Nat Commun. 2018;9(1):5460. doi:10.1038\/s41467-018-07730-9"},{"issue":"8","key":"ref28","series-title":"PLoS One","first-page":"e0273706","article-title":"The prevalence of the ABCB1-1\u0394 variant in a clinical veterinary setting: the risk of not genotyping","volume":"17","author":"Beckers E","year":"2022","unstructured":"Beckers E, Casselman I, Soudant E,  The prevalence of the ABCB1-1\u0394 variant in a clinical veterinary setting: the risk of not genotyping. PLoS One. 2022;17(8):e0273706. doi:10.1371\/journal.pone.0273706"},{"issue":"32","key":"ref29","series-title":"Proc Natl Acad Sci U S A","first-page":"11725","article-title":"Breed distribution and history of canine MDR1-1delta, a pharmacogenetic mutation that marks the emergence of breeds from the Collie lineage","volume":"101","author":"Neff MW","year":"2004","unstructured":"Neff MW, Robertson KR, Wong AK,  Breed distribution and history of canine MDR1-1delta, a pharmacogenetic mutation that marks the emergence of breeds from the Collie lineage. Proc Natl Acad Sci U S A. 2004;101(32):11725-11730. doi:10.1073\/pnas.0402374101"},{"issue":"2","key":"ref30","series-title":"PLoS Genet","first-page":"e1010651","article-title":"Genetic prevalence and clinical relevance of canine Mendelian disease variants in over one million dogs","volume":"19","author":"Donner J","year":"2023","unstructured":"Donner J, Freyer J, Davison S,  Genetic prevalence and clinical relevance of canine Mendelian disease variants in over one million dogs. PLoS Genet. 2023;19(2):e1010651. doi:10.1371\/journal.pgen.1010651"},{"key":"ref31","series-title":"Front Vet Sci","first-page":"1668282","article-title":"Assessment of clinically relevant drugs as feline P-glycoprotein substrates","volume":"12","author":"Mealey KL","year":"2025","unstructured":"Mealey KL, Burke NS. Assessment of clinically relevant drugs as feline P-glycoprotein substrates. Front Vet Sci. 2025;12:1668282. doi:10.3389\/fvets.2025.1668282. Published correction appears in Front Vet Sci. 2026;13:1867072. doi:10.3389\/fvets.2026.1867072"},{"issue":"5","key":"ref32","series-title":"J Am Vet Med Assoc","first-page":"559","article-title":"Topically administered macrocyclic lactone products, including eprinomectin, demonstrate comparable neurological safety in cats based on pharmacovigilance data","volume":"264","author":"Novotny MJ","year":"2026","unstructured":"Novotny MJ, Frana T, Silva M, Geary TG. Topically administered macrocyclic lactone products, including eprinomectin, demonstrate comparable neurological safety in cats based on pharmacovigilance data. J Am Vet Med Assoc. 2026;264(5):559-564. doi:10.2460\/javma.25.10.0669"}],"container-title":["Journal of the American Veterinary Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/aop\/javma.26.06.0483\/javma.26.06.0483.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/aop\/javma.26.06.0483\/javma.26.06.0483.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T17:36:17Z","timestamp":1791999377000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/aop\/javma.26.06.0483\/javma.26.06.0483.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,14]]},"references-count":32,"URL":"https:\/\/doi.org\/10.2460\/javma.26.06.0483","relation":{},"ISSN":["0003-1488"],"issn-type":[{"value":"0003-1488","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,14]]}}}